| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | PURPLE BIOTECH LTD. | 2,499,384 | 10.0% | EDGAR |
| SC 13G/A | 2021-04-09 | MORGAN STANLEY | PURPLE BIOTECH LTD. | 1,678,040 | 1.0% | EDGAR |
| SC 13G/A | 2021-02-16 | CVI Investments, Inc. | PURPLE BIOTECH LTD. | 1,348,889 | 0.8% | EDGAR |
| SC 13G/A | 2021-02-05 | Nussbaum Ran | PURPLE BIOTECH LTD. | 80,753 | 0.5% | EDGAR |
| SC 13G | 2021-02-04 | MORGAN STANLEY | PURPLE BIOTECH LTD. | 8,611,750 | 5.0% | EDGAR |
| SC 13G/A | 2021-01-05 | SABBY MANAGEMENT, LLC | PURPLE BIOTECH LTD. | 739,662 | 4.3% | EDGAR |
| SC 13G | 2020-07-06 | ARMISTICE CAPITAL, LLC | Kitov Pharma Ltd. | 8,259,048 | 5.0% | EDGAR |
| SC 13G | 2020-05-15 | ARMISTICE CAPITAL, LLC | Kitov Pharma Ltd. | 5,018,443 | 5.0% | EDGAR |
| SC 13G | 2020-05-06 | SABBY MANAGEMENT, LLC | Kitov Pharma Ltd. | 8,333,334 | 8.7% | EDGAR |
| SC 13G | 2020-03-23 | ARMISTICE CAPITAL, LLC | Kitov Pharma Ltd. | 2,104,107 | 5.0% | EDGAR |
| SC 13G | 2020-03-20 | CVI Investments, Inc. | Kitov Pharma Ltd. | 4,057,219 | 9.9% | EDGAR |
| SC 13G | 2020-02-13 | Nussbaum Ran | Kitov Pharma Ltd. | 1,560,566 | 5.1% | EDGAR |
| SC 13G/A | 2020-01-15 | Empery Asset Management, LP | Kitov Pharma Ltd. | 1,563,971 | 5.0% | EDGAR |
| SC 13G/A | 2020-01-02 | SABBY MANAGEMENT, LLC | Kitov Pharma Ltd. | 976,070 | 5.0% | EDGAR |
| SC 13G | 2019-01-24 | Empery Asset Management, LP | Kitov Pharma Ltd. | 1,731,286 | 8.9% | EDGAR |
| SC 13G | 2019-01-16 | SABBY MANAGEMENT, LLC | Kitov Pharma Ltd. | 1,714,286 | 8.8% | EDGAR |
| SC 13G/A | 2019-01-04 | SABBY MANAGEMENT, LLC | Kitov Pharma Ltd. | 779,980 | 4.9% | EDGAR |
| SC 13G | 2018-06-11 | ARMISTICE CAPITAL, LLC | Kitov Pharma Ltd. | 760,000 | 4.7% | EDGAR |
| SC 13G | 2018-06-05 | SABBY MANAGEMENT, LLC | Kitov Pharma Ltd. | 1,520,000 | 9.8% | EDGAR |
| SC 13G/A | 2018-05-15 | Rosalind Advisors, Inc. | Kitov Pharma Ltd. | 541,600 | 4.7% | EDGAR |